|
| | | | |
| | | |
| Stat |
Members: 3645
Articles: 2'503'724
Articles rated: 2609
24 April 2024 |
|
| | | | |
|
Article overview
| |
|
|
Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I | | S Z Salahuddin
; P D Markham
; S G Lindner
; J Gootenberg
; M Popovic
; H Hemmi
; P S Sarin
; R C Gallo
; | | Date: |
17 Feb 1984 | | Journal: | Science, 223 (4637), 703-7 | | Abstract: | Cell-free conditioned media from human T cells transformed by human T-cell leukemia-lymphoma virus (HTLV-I) were tested for the production of soluble biologically active factors, including several known lymphokines. The cell lines used were established from patients with T-cell leukemia-lymphoma and from human umbilical cord blood and bone marrow leukocytes transformed by HTLV-I in vitro. All of the cell lines liberated constitutively one or more of the 12 biological activities assayed. These included macrophage migration inhibitory factor (MIF), leukocyte migration inhibitory factor (LIF), leukocyte migration enhancing factor (MEF), macrophage activating factor (MAF), differentiation inducing factor (DIF), colony stimulating factor (CSF), eosinophil growth and maturation activity (eos. GMA), fibroblast activating factor (FAF), gamma-interferon and, in rare instances, T-cell growth factor (TCGF). Some cell lines produced interleukin 3 (IL-3), platelet-derived growth factor (PDGF), or B-cell growth factors (BCGF). Such cells should prove useful for the production of lymphokines and as sources of specific messenger RNA’s for their genetic cloning. | | Source: | PubMed, pmid6320367 | | Services: | Forum | Review | Favorites | |
|
|
No review found.
Did you like this article?
Note: answers to reviews or questions about the article must be posted in the forum section.
Authors are not allowed to review their own article. They can use the forum section.
browser Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)
|
| |
|
|
|
|
News, job offers and information for researchers and scientists:
| |
REGISTER